Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Nomura Holdings Inc.

Nomura Holdings Inc. cut its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 37.1% during the first quarter, Holdings Channel reports. The firm owned 17,963 shares of the medical instruments supplier’s stock after selling 10,599 shares during the period. Nomura Holdings Inc.’s holdings in Becton, Dickinson and were worth $3,294,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in BDX. BlackRock Inc. increased its position in shares of Becton, Dickinson and by 2,427.8% in the first quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock worth $3,034,470,000 after buying an additional 15,887,611 shares during the period. Vanguard Group Inc. increased its position in shares of Becton, Dickinson and by 5.3% in the first quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock worth $2,917,094,000 after buying an additional 796,034 shares during the period. Cantillon Capital Management LLC increased its position in shares of Becton, Dickinson and by 30.3% in the first quarter. Cantillon Capital Management LLC now owns 1,344,427 shares of the medical instruments supplier’s stock worth $246,622,000 after buying an additional 312,926 shares during the period. JPMorgan Chase & Co. increased its position in shares of Becton, Dickinson and by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock worth $727,863,000 after buying an additional 242,081 shares during the period. Finally, Prudential Financial Inc. increased its position in shares of Becton, Dickinson and by 34.0% in the first quarter. Prudential Financial Inc. now owns 930,445 shares of the medical instruments supplier’s stock worth $170,681,000 after buying an additional 236,280 shares during the period. 75.71% of the stock is owned by hedge funds and other institutional investors.

Shares of Becton, Dickinson and Company (BDX) traded up 0.34% during midday trading on Thursday, reaching $198.52. The company’s stock had a trading volume of 263,172 shares. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63. The company’s 50-day moving average price is $198.62 and its 200 day moving average price is $187.41. The firm has a market capitalization of $45.18 billion, a PE ratio of 57.49 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the consensus estimate of $2.44 by $0.02. The company had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business’s revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.35 EPS. On average, equities research analysts forecast that Becton, Dickinson and Company will post $9.45 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be given a $0.73 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.48%. Becton, Dickinson and’s payout ratio is 83.43%.

ILLEGAL ACTIVITY NOTICE: “Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Nomura Holdings Inc.” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2800267/becton-dickinson-and-company-nysebdx-shares-sold-by-nomura-holdings-inc.html.

A number of equities analysts recently issued reports on BDX shares. Zacks Investment Research downgraded Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Thursday, May 4th. Evercore ISI raised Becton, Dickinson and from an “in-line” rating to an “outperform” rating and upped their price target for the company from $186.00 to $200.00 in a report on Monday, April 24th. Raymond James Financial, Inc. raised Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their price target for the company from $210.00 to $180.00 in a report on Friday, June 30th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $177.00 price target on shares of Becton, Dickinson and in a report on Thursday, April 13th. Finally, Bank of America Corporation reaffirmed a “buy” rating and issued a $225.00 price target (up from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Becton, Dickinson and currently has a consensus rating of “Buy” and an average target price of $194.69.

In other news, VP Jeffrey S. Sherman sold 28,765 shares of Becton, Dickinson and stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total value of $5,349,714.70. Following the completion of the transaction, the vice president now owns 70,821 shares in the company, valued at approximately $13,171,289.58. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.40% of the stock is currently owned by company insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.